My Portfolio
+
LINK YOUR PORTFOLIO

Qiagen NV QGEN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
36.45UNCH (UNCH)
Volume
34,097
Close
36.45quote price arrow up+0.76 (+2.13%)
Volume
3,201,252
52 week range
32.53 - 57.82
Loading...
  • Open35.69
  • Day High36.51
  • Day Low35.47
  • Prev Close35.69
  • 52 Week High57.82
  • 52 Week High Date01/20/26
  • 52 Week Low32.53
  • 52 Week Low Date05/13/26

Key Stats

  • Market Cap7.518B
  • Shares Out206.25M
  • 10 Day Average Volume2.00M
  • Dividend0.35
  • Dividend Yield0.96%
  • Beta0.67

KEY STATS

  • Open35.69
  • Day High36.51
  • Day Low35.47
  • Prev Close35.69
  • 52 Week High57.82
  • 52 Week High Date01/20/26
  • 52 Week Low32.53
  • 52 Week Low Date05/13/26
  • Market Cap7.518B
  • Shares Out206.25M
  • 10 Day Average Volume2.00M
  • Dividend0.35
  • Dividend Yield0.96%
  • Beta0.67

RATIOS/PROFITABILITY

  • EPS (TTM)1.85
  • P/E (TTM)19.75
  • Fwd P/E (NTM)14.74
  • EBITDA (TTM)726.142M
  • ROE (TTM)11.93%
  • Revenue (TTM)2.099B
  • Gross Margin (TTM)62.59%
  • Net Margin (TTM)19.16%
  • Debt To Equity (MRQ)49.42%

EVENTS

  • Earnings Date08/05/2026(est)
  • Ex Div Date07/07/2026
  • Div Amount0.35
  • Split Date-
  • Split Factor-

Profile

MORE
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other...
Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Address
Hulsterweg 82
Venlo
5912 PL
Netherlands